No Data
No Data
Express News | Cocrystal Pharma Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Q3 Earnings Beat Reported on Wednesday
Noble Financial Maintains Cocrystal Pharma(COCP.US) With Buy Rating, Maintains Target Price $10
Cocrystal Pharma (COCP) Receives a Buy From Noble Financial
Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Cocrystal Pharma | 10-Q: Q3 2024 Earnings Report
Cocrystal Pharma Reports Q3 EPS (49c), Consensus (57c)